Lv4
470 积分 2024-09-19 加入
[Research progress of thrombolytic therapy for high risk and intermediate-high risk pulmonary thromboembolism]
7天前
已完结
Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo
1个月前
已完结
Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
2个月前
已完结
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease
2个月前
已完结
Pulmonary hypertension associated with lung diseases
2个月前
已完结
Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study
2个月前
已完结
circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
2个月前
已完结
Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival
2个月前
已完结
Targeting Pulmonary Hypertension Caused by Pulmonary Fibrosis: A Promising Natural Killer T Cell–based Therapy
2个月前
已完结
Surrogate endpoints in pulmonary arterial hypertension trials
2个月前
已完结
皖公网安备34019202002308
